|
Novohradsky V, Yellol J, Stuchlikova O, Santana MD, Kostrhunova H, Yellol G, Kasparkova J, Bautista D, Ruiz J, Brabec V. Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action. Chemistry. 2017 Nov 2;23(61):15294-15299. doi: 10.1002/chem.201703581. Epub 2017 Oct 13. PubMed PMID: 28922506.
AÑO: 2017; IF: 5.16
|
28922506
|
Zamora A, Denning CA, Heidary DK, Wachter E, Nease LA, Ruiz J, Glazer EC. Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage. Dalton Trans. 2017 Feb 14;46(7):2165-2173. doi: 10.1039/c6dt04405k. PubMed PMID: 28121322.
AÑO: 2017; IF: 4.099
|
|
Yellol J, Pérez SA, Yellol G, Zajac J, Donaire A, Vigueras G, Novohradsky V, Janiak C, Brabec V, Ruiz J. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization. Chem Commun (Camb). 2016 Dec 1;52(98):14165-14168. PubMed PMID: 27869279.
AÑO: 2016; IF: 6.319
|
|
Wachter E, Zamora A, Heidary DK, Ruiz J, Glazer EC. Geometry matters: inverse cytotoxic relationship for cis/trans-Ru(ii) polypyridyl complexes from cis/trans-[PtCl2(NH3)2]. Chem Commun (Camb). 2016 Aug 9;52(66):10121-4. doi: 10.1039/c6cc04813g. PubMed PMID: 27352966; PubMed Central PMCID: PMC4980196.
AÑO: 2016; IF: 6.319
|
|
Zamora A, Pérez SA, Rodríguez V, Janiak C, Yellol GS, Ruiz J. Dual antitumor and antiangiogenic activity of organoplatinum(II) complexes. J Med Chem. 2015 Feb 12;58(3):1320-36. doi: 10.1021/jm501662b. PubMed PMID: 25581345.
AÑO: 2015; IF: 5.589
|